← Back to Analyst Consensus 
IMVT Buy
Immunovant, Inc.
Current Price —
Implied Upside —
Analysts 23
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 4, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jun 30, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 26, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 22, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| May 21, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 21, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 15, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Mar 20, 2026 | Bernstein | initiate | — → Market Perform | — | 52% |
| Feb 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Feb 9, 2026 | Guggenheim | maintain | Buy → Buy | $44 | 52% |
| Jan 8, 2026 | Truist Securities | maintain | Hold → Hold | $22 | 54% |
| Jan 6, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | $50 | 53% |
| Dec 15, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $28 | 54% |
| Oct 14, 2025 | Truist Securities | initiate | — → Hold | $16 | 54% |
| Sep 30, 2025 | JP Morgan | maintain | Overweight → Overweight | $33 | 54% |
| Sep 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $35 | 44% |
| Aug 12, 2025 | JP Morgan | maintain | Overweight → Overweight | $37 | 54% |
| Aug 12, 2025 | B of A Securities | maintain | Buy → Buy | $30 | 53% |
| Jul 28, 2025 | UBS | maintain | Neutral → Neutral | $18 | 54% |
| Apr 22, 2025 | UBS | downgrade | Buy → Neutral | $17 | 54% |
| Mar 20, 2025 | Guggenheim | reiterate | Buy → Buy | $0 | 52% |
| Mar 20, 2025 | B of A Securities | maintain | Buy → Buy | $33 | 53% |
| Mar 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Mar 10, 2025 | Guggenheim | reiterate | Buy → Buy | $0 | 52% |
| Feb 10, 2025 | Guggenheim | maintain | Buy → Buy | $44 | 52% |
| Feb 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Feb 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Jan 15, 2025 | B of A Securities | maintain | Buy → Buy | $45 | 53% |
| Jan 3, 2025 | Wolfe Research | downgrade | Outperform → Peer Perform | $0 | 53% |
| Dec 19, 2024 | Wells Fargo | maintain | Overweight → Overweight | $45 | 54% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Oct 9, 2024 | Oppenheimer | maintain | Outperform → Outperform | $53 | 52% |
| Sep 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Sep 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 13, 2024 | UBS | maintain | Buy → Buy | $41 | 54% |
| Aug 8, 2024 | JP Morgan | maintain | Overweight → Overweight | $46 | 54% |
| Aug 7, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jun 20, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jun 18, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Jun 3, 2024 | Oppenheimer | maintain | Outperform → Outperform | $46 | 52% |
| May 30, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| May 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $51 | 44% |
| Mar 28, 2024 | Oppenheimer | initiate | — → Outperform | $50 | 52% |
| Mar 25, 2024 | Truist Securities | reiterate | Buy → Buy | $48 | 54% |
| Mar 13, 2024 | Goldman Sachs | initiate | — → Buy | $50 | 54% |
| Feb 20, 2024 | JP Morgan | initiate | — → Overweight | $51 | 54% |
| Feb 15, 2024 | Wolfe Research | initiate | — → Outperform | $55 | 53% |
| Dec 21, 2023 | B of A Securities | maintain | Buy → Buy | $51 | 53% |
| Dec 21, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $51 | 44% |
Price Target Trend
May 14, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days